المؤلفون: Hewitt, L. C., Inam, I. Z., Saito, Y., Yoshikawa, T., Quaas, A., Hoelscher, A., Bollschweiler, E., Fazzi, G. E., Melotte, V., Langley, R. E., Nankivell, M., Cunningham, D., Allum, W., Hutchins, G. G., Grabsch, H. I.

المصدر: Hewitt , L C , Inam , I Z , Saito , Y , Yoshikawa , T , Quaas , A , Hoelscher , A , Bollschweiler , E , Fazzi , G E , Melotte , V , Langley , R E , Nankivell , M , Cunningham , D , Allum , W , Hutchins , G G & Grabsch , H I 2018 , ' Epstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer : A large multi-centre study ' , European Journal of Cancer , vol. 94 , pp. 104-114 . ....

مصطلحات موضوعية: Oesophageal cancer, Gastric cancer, DNA mismatch repair, Microsatellite instability, Epsteine-Barr virus, SQUAMOUS-CELL CARCINOMA, NONPOLYPOSIS COLORECTAL-CANCER, CLINICAL-PRACTICE GUIDELINES, RANDOMIZED PHASE-3 TRIAL, HIGH-INCIDENCE AREA, MICROSATELLITE-INSTABILITY, PD-1 BLOCKADE, COLON-CANCER, DOUBLE-BLIND, OPEN-LABEL

الاتاحة: https://cris.maastrichtuniversity.nl/en/publications/00cb37d5-7aed-42e8-b26f-98920d70e81d
https://doi.org/10.1016/j.ejca.2018.02.014

المؤلفون: Horn, Leora, Gettinger, Scott, Camidge, D. Ross, Smit, Egbert F., Janjigian, Yelena Y., Miller, Vincent A., Pao, William, Freiwald, Matthias, Fan, Jean, Wang, Bushi, Chand, Vikram K., Groen, Harry J. M.

المصدر: Horn , L , Gettinger , S , Camidge , D R , Smit , E F , Janjigian , Y Y , Miller , V A , Pao , W , Freiwald , M , Fan , J , Wang , B , Chand , V K & Groen , H J M 2017 , ' Continued use of afatinib with the addition of cetuximab after progression on afatinib in patients with EGFR mutation-positive non-small-cell lung cancer and acquired resistance to gefitinib or erlotinib ' , Lung Cancer , vol. 113 , pp. 51-58 . https://doi.org/10.1016/j.lungcan.2017.08.014

مصطلحات موضوعية: Phase Ib, Afatinib, Cetuximab, NSCLC, EGFR, TYROSINE KINASE INHIBITORS, RANDOMIZED PHASE-3 TRIAL, GROWTH-FACTOR RECEPTOR, 1ST-LINE TREATMENT, OPEN-LABEL, CHEMOTHERAPY, ADENOCARCINOMA, HER2, MULTICENTER, MECHANISM

وصف الملف: application/pdf

Relation: https://research.rug.nl/en/publications/3a825068-c6df-49d0-ad95-42dc73e4cc9e

الاتاحة: https://hdl.handle.net/11370/3a825068-c6df-49d0-ad95-42dc73e4cc9e
https://research.rug.nl/en/publications/3a825068-c6df-49d0-ad95-42dc73e4cc9e
https://doi.org/10.1016/j.lungcan.2017.08.014
https://pure.rug.nl/ws/files/50615255/1_s2.0_S0169500217304877_main.pdf

المؤلفون: Palmieri, C, Macpherson, IRJ, Yan, K, Ades, F, Riddle, P, Ahmed, R, Owadally, W, Stanley, B, Shah, D, Gojis, O, Januszewski, A, Lewanski, C, Asher, R, Lythgoe, D, De Azambuja, E, Beresford, M, Howell, SJ

المساهمون: Cancer Research UK

المصدر: 13220 ; 13209

مصطلحات موضوعية: Science & Technology, Life Sciences & Biomedicine, Oncology, Cell Biology, breast, neoadjuvant, trastuzumab, concomitant, sequential, PATHOLOGICAL COMPLETE RESPONSE, RANDOMIZED PHASE-3 TRIAL, OPEN-LABEL, ADJUVANT CHEMOTHERAPY, PLUS TRASTUZUMAB, CONCURRENT TRASTUZUMAB, LAPATINIB, MULTICENTER, THERAPY, EPIRUBICIN

Relation: Oncotarget; http://hdl.handle.net/10044/1/38518; http://dx.doi.org/10.18632/oncotarget.4801; C20208/A8667; C20208/A13392

الاتاحة: http://hdl.handle.net/10044/1/38518
https://doi.org/10.18632/oncotarget.4801

المؤلفون: Vermassen, Tijl, Geboes, Karen, De Man, Marc, Laurent, Stéphanie, Decoene, Elsie, Lumen, Nicolaas, Delanghe, Joris, Rottey, Sylvie

المصدر: NEPHROLOGY DIALYSIS TRANSPLANTATION ; ISSN: 0931-0509 ; ISSN: 1460-2385

مصطلحات موضوعية: Medicine and Health Sciences, cathepsin D, cystatin C, GFR, oncology, tyrosine kinase inhibitors, RENAL-CELL CARCINOMA, METASTATIC COLORECTAL-CANCER, RANDOMIZED PHASE-3 TRIAL, CATHEPSIN-D EXPRESSION, SERUM CREATININE, THROMBOTIC MICROANGIOPATHY, PROGNOSTIC-FACTORS, BEVACIZUMAB, SURVIVAL, SORAFENIB

وصف الملف: application/pdf

Relation: https://biblio.ugent.be/publication/8521492; http://hdl.handle.net/1854/LU-8521492; http://dx.doi.org/10.1093/ndt/gfx063; https://biblio.ugent.be/publication/8521492/file/8679615

الاتاحة: https://biblio.ugent.be/publication/8521492
http://hdl.handle.net/1854/LU-8521492
https://doi.org/10.1093/ndt/gfx063
https://biblio.ugent.be/publication/8521492/file/8679615

المؤلفون: Hewitt, Lindsay C., Inam, Imran Z., Saito, Yuichi, Yoshikawa, Takaki, Quaas, Alexander, Hölscher, Arnulf H., Bollschweiler, Elfriede, Fazzi, Gregorio E., Melotte, Veerle, Langley, Ruth Elizabeth, Nankivell, Matthew, Cunningham, David, Allum, William, Hutchins, Gordon G., Grabsch, Heike Irmgard

المساهمون: Clinical Genetics, Promovendi ODB, Pathologie, RS: GROW - R2 - Basic and Translational Cancer Biology

المصدر: European Journal of Cancer, 94, 104-114. Elsevier Ltd.
European Journal of Cancer, 94, 104-114. ELSEVIER SCI LTD

مصطلحات موضوعية: HIGH-INCIDENCE AREA, Epsteine-Barr virus, Oesophageal cancer, DNA mismatch repair, COLON-CANCER, NONPOLYPOSIS COLORECTAL-CANCER, RANDOMIZED PHASE-3 TRIAL, OPEN-LABEL, PD-1 BLOCKADE, DOUBLE-BLIND, MICROSATELLITE-INSTABILITY, SDG 3 - Good Health and Well-being, hemic and lymphatic diseases, Microsatellite instability, ddc:610, SQUAMOUS-CELL CARCINOMA, CLINICAL-PRACTICE GUIDELINES, Gastric cancer

وصف الملف: application/octet-stream

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::019375e1e220cca54bc5dc9755a8ed56
https://pure.eur.nl/en/publications/bc70518e-1f1f-41c3-9057-e34beb60604b

المؤلفون: Wan, Rui, Wang, Zhijie, Lee, J. Jack, Wang, Shuhang, Li, Qingqing, Tang, Fuchou, Wang, Jin, Sun, Yu, Bai, Hua, Wang, Di, Zhao, Jun, Duan, Jianchun, Zhuo, Minglei, An, Tongtong, Wu, Meina, Chen, Zhaoli, Yang, Zhenlin, Wang, Jie

المساهمون: Wang, J (reprint author), Peking Union Med Coll, Panjiayuan Nanli 17, Beijing 100021, Peoples R China., Wang, J (reprint author), Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, Panjiayuan Nanli 17, Beijing 100021, Peoples R China., Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Thorac Med Oncol, Beijing, Peoples R China., Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, Dept Med Oncol, Beijing, Peoples R China., Peking Union Med Coll, Panjiayuan Nanli 17, Beijing 100021, Peoples R China., Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA., Peking Univ, Coll Life Sci, Biodynam Opt Imaging Ctr, Beijing, Peoples R China., Chongqing Med Univ, Affiliated Hosp 1, Dept Resp Med, Chongqing, Peoples R China., Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Pathol, Beijing, Peoples R China., Peking Univ, Acad Adv Interdisciplinary Studies, PekingTsinghua Ctr Life Sci, Beijing, Peoples R China., Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, Dept Thorac Oncol Surg, Beijing, Peoples R China.

المصدر: SCI

مصطلحات موضوعية: Epidermal growth factor receptor mutation, Non-small cell lung cancer, Circulating tumor DNA, Discordance of mutation, Heterogeneity, FACTOR RECEPTOR MUTATIONS, CISPLATIN PLUS GEMCITABINE, RANDOMIZED PHASE-3 TRIAL, OPEN-LABEL, 1ST-LINE TREATMENT, DIGITAL PCR, PLASMA DNA, NSCLC PATIENTS, GEFITINIB, CHEMOTHERAPY

Relation: JOURNAL OF THORACIC ONCOLOGY.2017,12(9),1376-1387.; 1905189; http://hdl.handle.net/20.500.11897/471138; WOS:000409157900008

الاتاحة: https://hdl.handle.net/20.500.11897/471138
https://doi.org/10.1016/j.jtho.2017.05.011

المؤلفون: Haemmerle, Monika, Bottsford-Miller, Justin, Pradeep, Sunila, Taylor, Morgan L., Choi, Hyun-Jin, Hansen, Jean M., Dalton, Heather J., Stone, Rebecca L., Cho, Min Soon, Nick, Alpa M., Nagaraja, Archana S., Gutschner, Tony, Gharpure, Kshipra M., Mangala, Lingegowda S., Rupaimoole, Rajesha, Han, Hee Dong, Zand, Behrouz, Armaiz-Pena, Guillermo N., Wu, Sherry Y., Pecot, Chad V., Burns, Alan R., Lopez-Berestein, Gabriel, Afshar-Kharghan, Vahid, Sood, Anil K.

مصطلحات موضوعية: Focal Adhesion Kinase, Metastatic Colorectal-Cancer, Recurrent Ovarian-Cancer, Randomized Phase-3 Trial, Open-Label, Paraneoplastic Thrombocytosis, Megakaryocyte Lineage, Intermittent Hypoxia, Cerebral-Ischemia, Aurelia Trial

Relation: orcid:0000-0002-6051-4252; CA177909; CA016672; CA109298; UH2TR000943; P50 CA083639; P50 CA098258; RP110595; RP120214; Not set; T32 CA101642; RP101502; RP101489; P30CA16672; P50CA098258; P30CA016672; T32CA101642

الاتاحة: https://espace.library.uq.edu.au/view/UQ:8d3f37c

المؤلفون: Muscella, A, Vetrugno, C, Biagioni, F, Calabriso, N, Calierno, Mt, De Pascali, Sa, Marsigliante, S, Fanizzi, F.p., FORNAI, FRANCESCO

المساهمون: Muscella, A, Vetrugno, C, Biagioni, F, Calabriso, N, Calierno, Mt, Fornai, Francesco, De Pascali, Sa, Marsigliante, S, Fanizzi, F. p.

مصطلحات موضوعية: RANDOMIZED PHASE-3 TRIAL, BREAST-CANCER CELLS, TUMOR ANGIOGENESIS, TESTICULAR CANCER, PLATINUM(II) COMPLEXES, ENDOTHELIAL-CELL, IN-VIVO, GROWTH, CISPLATIN, PATHWAY

وصف الملف: STAMPA

Relation: info:eu-repo/semantics/altIdentifier/pmid/27351124; info:eu-repo/semantics/altIdentifier/wos/WOS:000383258400006; volume:173; issue:17; firstpage:2633; lastpage:2644; numberofpages:12; journal:BRITISH JOURNAL OF PHARMACOLOGY; http://hdl.handle.net/11568/804035; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84981287692

الاتاحة: http://hdl.handle.net/11568/804035
https://doi.org/10.1111/bph.13543

المؤلفون: Vermassen, Tijl, De Meulenaere, Astrid, Van de Walle, M., Rottey, Sylvie

المصدر: ACTA CLINICA BELGICA ; ISSN: 1784-3286 ; ISSN: 2295-3337

مصطلحات موضوعية: Medicine and Health Sciences, Renal cell carcinoma, surgery, systemic therapy, RANDOMIZED PHASE-3 TRIAL, CHRONIC KIDNEY-DISEASE, RADICAL NEPHRECTOMY, INTERFERON-ALPHA, III TRIAL, DOUBLE-BLIND, CYTOREDUCTIVE NEPHRECTOMY, RADIOFREQUENCY ABLATION, SURGICAL-MANAGEMENT, PROGNOSTIC-FACTORS

وصف الملف: application/pdf

Relation: https://biblio.ugent.be/publication/8521482; http://hdl.handle.net/1854/LU-8521482; http://dx.doi.org/10.1080/17843286.2016.1193269; https://biblio.ugent.be/publication/8521482/file/8521483

الاتاحة: https://biblio.ugent.be/publication/8521482
http://hdl.handle.net/1854/LU-8521482
https://doi.org/10.1080/17843286.2016.1193269
https://biblio.ugent.be/publication/8521482/file/8521483

المؤلفون: Xu, Naiqing, Fang, Wenfeng, Mu, Libing, Tang, Yanna, Gao, Lei, Ren, Shengxiang, Cao, Dengfeng, Zhou, Lixin, Zhang, Aiqun, Liu, Deruo, Zhou, Caicun, Wong, Kwok-Kin, Yu, Lei, Zhang, Li, Chen, Liang

المساهمون: Chen, L (reprint author), Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China., Chen, L (reprint author), Natl Inst Biol Sci, Beijing, Peoples R China., Chen, L (reprint author), Chinese Acad Med Sci, Beijing 100730, Peoples R China., Zhang, L (reprint author), Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China., Chen, L (reprint author), Collaborat Innovat Ctr Canc Med, Natl Inst Biol Sci, Beijing, Peoples R China., Peking Union Med Coll, Grad Sch, Beijing 100021, Peoples R China., Natl Inst Biol Sci, Beijing, Peoples R China., Chinese Acad Med Sci, Beijing 100730, Peoples R China., Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, Guangzhou 510275, Guangdong, Peoples R China., Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China., Shanghai Pulm Hosp, Shanghai, Peoples R China., Chinese Acad Med Sci, Canc Hosp & Inst, Beijing 100730, Peoples R China., Peking Univ, Canc Hosp, Beijing 100871, Peoples R China., Gen Hosp Peoples Liberat Army, Beijing, Peoples R China., China Japan Friendship Hosp, Dept Thorac Surg, Beijing, Peoples R China., Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA., Capital Med Univ, Beijing Tongren Hosp, Beijing, Peoples R China., Collaborat Innovat Ctr Canc Med, Natl Inst Biol Sci, Beijing, Peoples R China.

المصدر: PubMed ; SCI

مصطلحات موضوعية: EGFR, transgenic mouse model, tyrosine kinase inhibitor, lung cancer, GROWTH-FACTOR-RECEPTOR, RANDOMIZED PHASE-3 TRIAL, KINASE DOMAIN MUTATIONS, GENE COPY NUMBER, 1ST-LINE TREATMENT, OPEN-LABEL, GEFITINIB SENSITIVITY, MOLECULAR PREDICTORS, EXPRESSION, ERLOTINIB

Relation: ONCOTARGET.2016,7,(4),3884-3896.; 1392115; http://hdl.handle.net/20.500.11897/435973; WOS:000369952400019

الاتاحة: https://hdl.handle.net/20.500.11897/435973
https://doi.org/10.18632/oncotarget.6461

المؤلفون: Muscella, A, Vetrugno, C, Biagioni, F, Calabriso, N, Calierno, Mt, Fornai, Francesco, De Pascali, Sa, Marsigliante, S, Fanizzi, F. p.

المساهمون: Muscella, Antonella, Vetrugno, Carla, Biagioni, F, Calabriso, Nadia, Calierno, M. T, Fornai, F, DE PASCALI, SANDRA ANGELICA, Marsigliante, Santo, Fanizzi, Francesco Paolo

المصدر: British journal of pharmacology. 173(17)

مصطلحات موضوعية: RANDOMIZED PHASE-3 TRIAL, BREAST-CANCER CELLS, TUMOR ANGIOGENESIS, TESTICULAR CANCER, PLATINUM(II) COMPLEXES, ENDOTHELIAL-CELL, IN-VIVO, GROWTH, CISPLATIN, PATHWAY, Organoplatinum Compounds, Cell Survival, Mice, Nude, Angiogenesis Inhibitors, Antineoplastic Agents, renal cell carcinoma, VEGF, xenograft, [Pt(O,O′-acac)(γ-acac)(DMS)], MMPs matrix metalloprotease, Mice, Structure-Activity Relationship, Tumor Cells, Cultured, Animals, Humans, Carcinoma, Renal Cell, Cell Proliferation, Mice, Inbred BALB C, Dose-Response Relationship, Drug, Neoplasms, Experimental, Xenograft Model Antitumor Assays, Research Papers, Kidney Neoplasms

وصف الملف: STAMPA

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::b380408814aac242a521830ef6000e42
https://pubmed.ncbi.nlm.nih.gov/27351124

المؤلفون: Landi L, Tiseo M, Chiari R, Ricciardi S, Rossi E, Galetta D, Novello S, Milella M, D'Incecco A, Minuti G, Tibaldi C, Salvini J, Facchinetti F, Haspinger E. R, Cortinovis D, Santo A, Banna G, Catino A, GiajLevra M, De Marinis F, Cappuzzo F., CRINO', Lucio

المساهمون: Landi, L, Tiseo, M, Chiari, R, Ricciardi, S, Rossi, E, Galetta, D, Novello, S, Milella, M, D'Incecco, A, Minuti, G, Tibaldi, C, Salvini, J, Facchinetti, F, Haspinger, E. R., Cortinovis, D, Santo, A, Banna, G, Catino, A, Giajlevra, M, Crino', Lucio, De Marinis, F, Cappuzzo, F.

مصطلحات موضوعية: RANDOMIZED PHASE-3 TRIAL, OPEN-LABEL, 1ST-LINE TREATMENT, GEFITINIB FAILURE, CLINICAL BENEFIT, T790M MUTATION, ASIAN PATIENTS, SOLID TUMORS, ERLOTINIB, CHEMOTHERAPY

وصف الملف: STAMPA

Relation: info:eu-repo/semantics/altIdentifier/wos/WOS:000343791100004; volume:15; issue:6; firstpage:411; lastpage:417; numberofpages:7; journal:CLINICAL LUNG CANCER; http://hdl.handle.net/11391/1333106; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84908131211

الاتاحة: http://hdl.handle.net/11391/1333106
https://doi.org/10.1016/j.cllc.2014.07.002

المؤلفون: Kim, Kihyun, Lee, Jae Hoon, Kim, Jin Seok, Min, Chang Ki, Yoon, Sung Soo, Shimizu, Kazuyuki, Chou, Takaaki, Kosugi, Hiroshi, Suzuki, Kenshi, Chen, Wenming, Hou, Jian, Lu, Jin, Huang, Xiao-Jun, Huang, Shang-Yi, Chng, Wee Joo, Tan, Daryl, Teoh, Gerrard, Chim, Chor Sang, Nawarawong, Weerasak, Siritanaratkul, Noppadol, Durie, Brian G.

المساهمون: Lee, JH (reprint author), Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Hematol Oncol, 1198 Guwol Dong, Inchon 405220, South Korea., Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea., Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Hematol Oncol, Inchon 405220, South Korea., Yonsei Univ, Coll Med, Severance Hosp, Div Hematol,Dept Internal Med, Seoul, South Korea., Catholic Univ Korea, Seoul St Marys Hosp, Dept Internal Med, Seoul, South Korea., Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea., Tokai Cent Hosp, Dept Hematol, Kakamigahara, Japan., Niigata Canc Ctr Hosp, Dept Internal Med, Niigata, Japan., Ogaki Municipal Hosp, Dept Hematol, Ogaki, Japan., Japanese Red Cross Med Ctr, Dept Hematol, Tokyo, Japan., Capital Med Univ, Beijing Chaoyang Hosp, Dept Hematol, Beijing, Peoples R China., Chang Zheng Hosp, Dept Hematol, Myeloma & Lymphoma Ctr, Shanghai, Peoples R China., Peking Univ, Inst Hematol, Peking Univ Peoples Hosp, Dept Hematol, Beijing 100871, Peoples R China., Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan., Natl Univ Hlth Syst, Natl Univ Canc Inst Singapore, Dept Haematol Oncol, Singapore, Singapore., Raffles Hosp, Raffles Canc Ctr, Dept Internal Med, Singapore, Singapore., Singapore Gen Hosp, Dept Hematol, Dept Med, Singapore, Singapore., Novena Med Ctr, Gerrard Teoh Hematol & Med Clin, Singapore, Singapore., Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China., Chiang Mai Med Sch, Dept Med, Maung, Thailand., Siriraj Hosp, Dept Med, Div Hematol, Bangkok, Thailand., Cedars Sinai Comprehens Canc Ctr, Dept Hematol, Los Angeles, CA USA., Gachon Univ, Gil Med Ctr, Dept Internal Med, Div Hematol Oncol, 1198 Guwol Dong, Inchon 405220, South Korea.

المصدر: SCI

مصطلحات موضوعية: CHRONIC LYMPHOCYTIC-LEUKEMIA, COMPLEMENT-DEPENDENT CYTOTOXICITY, RANDOMIZED PHASE-3 TRIAL, COATED TARGET-CELLS, HIGH-RISK, RICHTER SYNDROME, NK ACTIVATION, GENE MUTATION, CD20 LOSS, ALEMTUZUMAB

Relation: AMERICAN JOURNAL OF HEMATOLOGY.2014,89,(7),751-765.; 956284; http://hdl.handle.net/20.500.11897/248006; WOS:000338029300014

الاتاحة: https://hdl.handle.net/20.500.11897/248006
https://doi.org/10.1002/ajh.23731

المؤلفون: Matteo Giaj-Levra, Filippo de Marinis, Lorenza Landi, Federico Cappuzzo, Domenico Galetta, Lucio Crinò, Rita Chiari, Antonio Santo, Annamaria Catino, Marcello Tiseo, Francesco Facchinetti, Serena Ricciardi, Gabriele Minuti, Carmelo Tibaldi, Eva Regina Haspinger, Giuseppe Luigi Banna, Jessica Salvini, Elisa Rossi, Diego Cortinovis, Silvia Novello, Armida D'Incecco, Michele Milella

مصطلحات موضوعية: GEFITINIB FAILURE, Oncology, Male, Cancer Research, Lung Neoplasms, Receptor, ErbB-2, Afatinib, medicine.medical_treatment, CLINICAL BENEFIT, Drug Resistance, NSCLC, T790M, ErbB-2, Carcinoma, Non-Small-Cell Lung, 80 and over, Neoplasm Metastasis, Non-Small-Cell Lung, Aged, 80 and over, education.field_of_study, medicine.diagnostic_test, ASIAN PATIENTS, Gefitinib, CHEMOTHERAPY, Middle Aged, OPEN-LABEL, SOLID TUMORS, ErbB Receptors, Treatment Outcome, Erlotinib, Female, medicine.drug, Receptor, Pulmonary and Respiratory Medicine, Adult, Diarrhea, medicine.medical_specialty, Population, Antineoplastic Agents, RANDOMIZED PHASE-3 TRIAL, T790M MUTATION, Disease-Free Survival, Internal medicine, Biopsy, medicine, Humans, education, Lung cancer, neoplasms, Protein Kinase Inhibitors, Aged, Neoplasm Staging, Retrospective Studies, Chemotherapy, business.industry, Carcinoma, medicine.disease, 1ST-LINE TREATMENT, ERLOTINIB, respiratory tract diseases, Drug Resistance, Neoplasm, Mutation, Quinazolines, Neoplasm, Acquired resistance, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8488129bc98d090e9dc7ab2cccdb307
http://hdl.handle.net/11562/1065692